Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
337
52
60
61
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.7%
9 terminated/withdrawn out of 337 trials
87.1%
+0.6% vs industry average
10%
35 trials in Phase 3/4
7%
4 of 61 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (337)
A Study on the Efficacy and User Experience of Gamified Intervention for Children With Anisometropic Amblyopia
Role: lead
99Tc-MDP Treatment for Knee Osteoarthritis
Role: lead
A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
Role: lead
Predicting the Metabolic Biomarkers Associated With Injury in Athletes
Role: lead
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
Role: lead
Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)
Role: lead
Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect
Role: lead
Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect
Role: lead
Digital Therapy for Fatty Liver Disease
Role: lead
A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children
Role: lead
Effects of Different Music Tempos on Feeding Outcomes in Preterm Infants
Role: lead
Effect of Probiotic on Gut Microbiota in Young Children With Functional Constipation
Role: collaborator
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
Role: collaborator
The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules
Role: lead
AI-Based Ultrasound Prediction of Pregnancy Outcomes in Placental-Related Fetal Growth Restriction (MVM-FGR): A Prospective Cohort Study
Role: lead
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
Role: collaborator
Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease
Role: lead
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Role: collaborator
AI-Powered Precision Decision-Making for Pancreatic Diseases
Role: collaborator
Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus
Role: lead